Cosciens Biopharma Inc. (CSCI) at a glance

Cosciens Biopharma Inc. (CSCI) is a micro-cap Healthcare company. It trades at $2.98, with a 49.3% profit margin and revenue growth of 83.3%. It does not pay a dividend. Vestovix scores it 63/100 overall. Its strongest dimension is Growth (81/100) and its weakest is Income (40/100).

Price
CA$2.98
Market cap
$6.3M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
CA$1.10 to CA$6.00
Vestovix Score63/ 100How this works
Value
73
Growth
81
Income
40
Safety
62
Momentum
41

Other Healthcare stocks

See all